Introducing the BECT (biologically enhanced cytotoxic treatment) concept in cancer treatment

Annals of Oncology

Volumn 16, Issue 11, 2005, Pages 1722-

  Bernier, J ^a   Bourhis, J ^b  

^a ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

^b INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIFOSTINE; ANGIOGENESIS INHIBITOR; BIOLOGICAL FACTOR; BIOLOGICAL RESPONSE MODIFIER; CYCLOOXYGENASE 2 INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR; HEPARAN SULFATE; OMEGA 3 FATTY ACID; PROTEIN TYROSINE KINASE;

ANTINEOPLASTIC ACTIVITY; BIOLOGICALLY ENHANCED CYTOTOXIC TREATMENT; CANCER RADIOTHERAPY; CANCER THERAPY; CELL CYCLE; DRUG EFFICACY; DRUG TARGETING; EDITORIAL; GENE THERAPY; HUMAN; METHODOLOGY; MORBIDITY; PRIORITY JOURNAL; PROCESS OPTIMIZATION; RADIATION INJURY; RADIOSENSITIZATION; SIGNAL TRANSDUCTION; TUMOR CELL;

ANTINEOPLASTIC AGENTS; CELL SURVIVAL; COMBINED MODALITY THERAPY; HUMANS; NEOPLASMS; RADIOTHERAPY DOSAGE; TUMOR MARKERS, BIOLOGICAL;

EID: 27744591104     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdi359     Document Type: Editorial

References (3)

1. Cooper JS, Ang KK. Concomitant chemotherapy and radiation therapy certainly improves local control. Int J Radiat Oncol Biol Phys 2005; 61: 7-9.
2. Bonner JA, Giralt J, Harari PM et al. Cetuximab prolongs survival in patients with locoregionally advanced squamous cell carcinoma of the head and neck: A phase III study of high dose radiation therapy with or without cetuximab. Proc Am Soc Clin Oncol 2004; Abstr 5507.
3. Wen B, Deutsch E, Opolon O et al. n-3 polyunsaturated fatty acids decrease mucosal/epidermal reactions and enhance antitumour effect of ionising radiation with inhibition of tumour angiogenesis. Br J Cancer 2003; 89: 1102-1107.